Aldeyra Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Aldeyra Therapeutics, Inc.‘s stocks are currently a part of 98 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 38.61M shares of Aldeyra Therapeutics, Inc.. Compared to the previous quarter, the number grew by 5.80% or 2.11M shares more. As for the holding position changes, 33.67% (33) of current hedge fund investors increased the number of shares held, 35.71% (35) of current holders sold a part of the shares held, and 22.45% (22) closed the holdings completely. 12 hedge funds are new holders of Aldeyra Therapeutics, Inc. stock in Q1 2022, it is 12.24% of total holders.
Hedge funds holding Aldeyra Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 24 |
|---|---|
| Q3 2017 | 35 |
| Q4 2017 | 36 |
| Q1 2018 | 43 |
| Q2 2018 | 66 |
| Q3 2018 | 90 |
| Q4 2018 | 75 |
| Q1 2019 | 77 |
| Q2 2019 | 75 |
| Q3 2019 | 70 |
| Q4 2019 | 76 |
| Q1 2020 | 69 |
| Q2 2020 | 81 |
| Q3 2020 | 83 |
| Q4 2020 | 94 |
| Q1 2021 | 106 |
| Q2 2021 | 131 |
| Q3 2021 | 113 |
| Q4 2021 | 109 |
| Q1 2022 | 98 |
Hedge funds changes in Aldeyra Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 6 | 7 | 6 | 6 | -1 |
|---|---|---|---|---|---|
| Q3 2017 | 15 | 13 | 5 | 3 | -1 |
| Q4 2017 | 9 | 12 | 8 | 8 | -1 |
| Q1 2018 | 11 | 18 | 4 | 4 | 6 |
| Q2 2018 | 28 | 19 | 5 | 5 | 9 |
| Q3 2018 | 32 | 31 | 13 | 8 | 6 |
| Q4 2018 | 12 | 33 | 18 | 26 | -14 |
| Q1 2019 | 14 | 33 | 20 | 13 | -3 |
| Q2 2019 | 16 | 30 | 16 | 16 | -3 |
| Q3 2019 | 5 | 29 | 19 | 10 | 7 |
| Q4 2019 | 17 | 31 | 18 | 11 | -1 |
| Q1 2020 | 9 | 22 | 23 | 15 | 0 |
| Q2 2020 | 29 | 19 | 26 | 18 | -11 |
| Q3 2020 | 24 | 28 | 20 | 22 | -11 |
| Q4 2020 | 23 | 28 | 24 | 11 | 8 |
| Q1 2021 | 33 | 30 | 24 | 19 | 0 |
| Q2 2021 | 46 | 43 | 27 | 21 | -6 |
| Q3 2021 | 15 | 29 | 43 | 32 | -6 |
| Q4 2021 | 19 | 39 | 33 | 23 | -5 |
| Q1 2022 | 12 | 33 | 35 | 22 | -4 |
Hedge funds changes in Aldeyra Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 377,000 | 0 |
| Q2 2018 | 42,000 | 3,000 |
| Q3 2018 | 1,983,000 | 571,000 |
| Q4 2018 | 436,000 | 86,000 |
| Q1 2019 | 4,366,000 | 3,326,000 |
| Q2 2019 | 761,000 | 255,000 |
| Q3 2019 | 76,000 | 207,000 |
| Q4 2019 | 213,000 | 405,000 |
| Q1 2020 | 27,000 | 39,000 |
| Q2 2020 | 454,000 | 100,000 |
| Q3 2020 | 919,000 | 315,000 |
| Q4 2020 | 689,000 | 2,183,000 |
| Q1 2021 | 4,160,000 | 4,953,000 |
| Q2 2021 | 6,712,000 | 4,211,000 |
| Q3 2021 | 19,053,000 | 2,182,000 |
| Q4 2021 | 8,710,000 | 4,789,000 |
| Q1 2022 | 3,430,000 | 4,783,000 |